Dow Up 0.09% Nasdaq Down 0.02%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
7.25 0.26(3.72%) Aug 27, 4:00PM EDT
|After Hours : 7.26 Up 0.01 (0.14%) Aug 27, 6:39PM EDT
Prev Close:6.99
Open:6.96
Bid:7.26 x 100
Ask:7.49 x 200
1y Target Est:12.89
Beta:1.97
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:6.87 - 7.45
52wk Range:6.04 - 13.64
Volume:1,067,386
Avg Vol (3m):1,137,130
Market Cap:314.48M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACRXUp 3.72%314.48M
BAX40.81B
CFN9.21B
HSP9.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.09
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback